ERA-EDTA Registry – looking back at the most recent years of contract

2018 will be the year of contract renewal between ERA-EDTA and AMC in Amsterdam (The Netherlands) on the Registry. We take this opportunity to report on the achievements of the Registry over the last three and a half years during which Ziad Massy took over as Registry Chairman from Christoph Wanner.
The first task of the Registry is to collect data on renal replacement therapy (RRT) from  national and regional registries in the ERA-EDTA area. This resulted in 4 ERA-EDTA Registry Annual Reports and slide series for download at the Registry’s website (https://www.era-edta-reg.org ). The most recent annual report includes data from 52 national and regional registries in 36 countries (Figure).

figure

Recently the new ERA-EDTA coding system for PRD underwent minor revision. This version is to appear online early 2018. The ERA-EDTA Registry Collaborative Research Network has been further extended  as a result of the work on CKD prevalence (under the umbrella of the EU sysKID project and the CKD Burden Consortium) and on EURODOPPS. The current focus is on the EQUAL study, a study of elderly patients with advanced CKD on if and when to start dialysis. Since 2014 the Registry has hosted 18 visiting researchers from Europe, Latin America and Asia. Seven of them came to work on the EURODOPPS data. From 2017 the Registry has started contributing to the EU Effect of Differing Kidney Disease Treatment Modalities and Organ Donation and Transplantation Practices on Health Expenditure and Patient Outcomes (EDITH) Consortium. So far the work has resulted in 87 publications as listed in the appendix, an additional 6 papers in press and another 12 papers submitted. This comes down to an average of 25 journal papers per year.
The educational activities of the Registry included the organization and teaching of 5 regular and 2 special editions of the ERA-EDTA Introductory course to Epidemiology. The special editions took place in Cape Town (WCN, 2015) and Yaounde (AFRAN, 2017). In addition, there was 1 NDT course for Reviewers-to-be.  Both Kitty Jager and Friedo Dekker served as editors for the NDT Perspectives Series and continued a series of of educational papers in NDT. This led to a  special NDT supplement Clinical Epidemiology in Nephrology  for which both were guest editors. Finally, the Registry organized 4 CME courses  Cross-talk in Renal Epidemiology  on the first day of the ERA-EDTA Congress and presented 4 ERA-EDTA Registry symposia on the the following day.
The Registry activities at AMC received  certification for NEN-EN ISO 9001:2015 and were evaluated positively by the ERA-EDTA Registry Committee.
The Registry would like to thank all patients and staff from dialysis and transplant units, the national and regional registries, nephrology researchers and ERA-EDTA who have made its work possible.  

Appendix      Scientific papers published June 2014 – November 2017 (excluding abstracts)

  1. Caskey FJ, Jager KJ. A Population Approach to Renal Replacement Therapy Epidemiology: lessons from the EVEREST Study. Nephrol Dial Transplant 2014;29:1494-9.
  2. Chesnaye N, Bonthuis M, Schaefer F, Groothoff JW, Verrina E, Heaf JG, Jankauskiene A, Lukosiene V, Molchanova EA, Mota C, Peco-Antić A, Ratsch IM, Bjerre A, Roussinov DL, Sukalo A, Topaloglu R, van Hoeck K, Zagozdzon I, Jager KJ, van Stralen KJ. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry. Ped Nephrol 2014;29:2403-10.
  3. Van der Veer SN, Van Biesen W, Couchoud C, Tomson CRV, Jager KJ. Measuring the quality of renal care: things to keep in mind when selecting and using quality indicators. Nephrol Dial Transplant 2014;29:1460-7.
  4. Leffondré K, Jager KJ, Boucquemont J, Stel VS, Heinze G. Representation of  exposures in regression analysis and interpretation of regression coefficients: basic concepts and pitfalls. Nephrol Dial Transplant 2014;29:1806-14.
  5. KJ van Stralen, D Borzych-Dużałka, H Hataya, SE Kennedy, KJ Jager, E Verrina, C Inward, K Rönnholm, K Vondrak, A Zurowska, F Schaefer, and P Cochat. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 2014;86:168-174
  6. Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager KJ. Renal replacement therapy in Ukraine: epidemiology and international comparisons. Clin Kidney J 2014;7: 330-335
  7. Wühl E, van Stralen KJ, Wanner C, Ariceta G, Heaf J, Bjerre A, Palsson R, Duneau G, Hoitsma AJ, Ravani P, Schaefer F,Jager KJ. Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry . Nephrol Dial Transplant 2014;29(suppl. 4):piv1-iv8.
  8. Spithoven E, Kramer A, Meijer E, Orskov B, Wanner C, Abad J, Alonso de la Torre R, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma AJ, De Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort R.  Renal replacement therapy for ADPKD in Europe: prevalence and survival. An analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant 2014;29(suppl. 4): iv15-iv25.
  9. Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N; CDC-CKD Surveillance Team, Brück K, Wanner C, Stel VS; European CKD Burden Consortium, Venuthurupalli SK, Hoy WE, Healy HG, Salisbury A, Fassett RG; CKD.QLD group, O'Donoghue D, Roderick P, Matsuo S, Hishida A, Imai E, Iimuro S. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int 2014;86:246-50.
  10. Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty D, Groothoff JW, Hoitsma A, Nogier MB,Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT.  Analysis of data from the ERA-EDTA Registry indicates that conventional treatmentsfor  CKD do not reduce the need for RRT in ADPKD. Kidney Int 2014;86:1244-1252.
  11. Wolbers M, Koller MT, Stel VS, Schaer B, Jager KJ, Leffondré K, Heinze G.  Competing risks analyses: objectives and approaches. Eur Heart J 2014;35:2936-41.
  12. Tjaden LA, Vogelzang J, Jager KJ, van Stralen KJ, Grootenhuis MA, Maurice-Stam H, Groothoff JW. Long-term quality of life and social outcome of childhood end-stage renal disease. J of Pediatrics 2014;165:336-342.e1
  13. Noordzij M, Jager KJ, van der Veer SN, Kramar R, Collart F, Heaf J, Stojceva-Taneva O, Leivestad T, Buturovic J, Benítez Sánchez M, Moreso F, Prütz KG, Severn A, Wanner C, Vanholder R, Ravani P. Use of Vascular Access for Haemodialysis in Europe: A report from the ERA-EDTA Registry. Nephrol Dial Transplant 2014;29:1956-1964.
  14. Noordzij M, Jager KJ. Patient survival on dialysis  in Korea: a different story. Kidney Int 2014;86:877-880.
  15. van der Veer SN., Ravani P, Coentrão L, Fluck R, Kleophas W, Labriola L, Hoischen SH, Noordzij M, Jager KJ, van Biesen W. Barriers to adopting a fistula-first policy in Europe: an international survey among national experts. J Vasc Access 2015;16:113-119.
  16. Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O, van Biesen W. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. Nephrol Dial Transplant 2015;30:310-320
  17. Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D. Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant 2015;30:1237-43.
  18. Guideline development group (including KJ Jager).  Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). Nephrol Dial Transplant. 2015 May;30 Suppl 2:ii1-ii142.
  19. Suttorp MM, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Graphical presentation of confounding in directed acyclic graph. Nephrol Dial Transplant 2015;30:1418-1423.
  20. Vogelzang JL, van Stralen KJ, Noordzij M, Abad Diez JA, Carrero JJ, Cecile Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hoitsma A, Leivestad T, de Meester J, Metcalfe W, Palsson R, Postorino M, Ravani P, Vanholder R, Wallner M, Wanner C, Groothoff JW, Jager KJ.Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2015;30:1028-1037.
  21. Van Dijk PR, Kramer A, Logtenberg SJJ, Hoitsma AJ, Kleefstra N, Jager KJ, Bilo HJG. Incidence of renal replacement therapy for diabetic nephropathy in The Netherlands: Dutch diabetes estimates (DUDE)-3. BMJ Open 30 January 2015;5(1):e005624.
  22. Bonthuis M, Busutti M, van Stralen KJ, Jager KJ, Baiko S, Bakkaloğlu S, Battelino N, Gaydarova M, Gianoglio B, Parvex P, Gomes C, Heaf JG, Podracka L, Kuzmanovska D, Molchanova MS, Pankratenko TE, Papachristou F, Reusz G, Sanahuja MJ, Shroff R, Groothoff JW, Schaefer F, Verrina E. Mineral Metabolism in European Children Living with a Renal Transplant: A European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association Registry Study. Clin J Am Soc Nephrol 2015;10:767-775.
  23. Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamaño E, Buturovic-Ponikvar J, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, de los Ángeles García Bazaga M, De Meester J, Manuel Díaz J, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, González Fernández R, Gutiérrez Avila G, Heaf J, Hoitsma A, Kantaria N, Kolesnyk M, Kramar R, Kramer A, Lassalle M, Leivestad T, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Noordzij M, Palsson R, Pechter U, Prütz KG, Ratkovic M, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Süleymanlar G, Van Stralen KJ, Thereska N, Wanner C, and Jager KJ. Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report. Clin Kidney Journal 2015;8:248-261.
  24. Chesnaye NC, Schaefer F, Groothoff JW, Caskey FJ, Heaf JG, Kushnirenko S, Lewis M, Mauel R, Maurer E, Merenmies J, Shtiza D, Topaloglu R, Zaicova N, Zampetoglou A, Jager KJ, van Stralen KJ. Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry. Nephrol Dial Transplant 2015;30:1377-1385.
  25. Koopman JJ, Rozing MP, Kramer A, Abad JM, Finne P, Heaf JG, Hoitsma AJ, De Meester JMJ, Palsson R, Postorino M, Ravani P, Wanner C, Jager KJ, van Bodegom D, Westendorp RGJ. Calculating the rate of senescence from mortality data: an analysis of data from the ERA-EDTA Registry.  J Gerontol A Biol Sci Med Sci 2016;71:468-74.
  26. Tripepi G, Heinze G, Jager KJ, Stel VS, Dekker FW, Zoccali C. Lag-censoring analysis: lights and shades. Nephrol Dial Transplant 2015; 30:700-705.
  27. van Huis M, Bonthuis M, Sahpazova E, Mencarelli F, Spasojević B, Reusz G, Caldas-Afonso A, Bjerre A, Baiko S, Vondrak K, Molchanova EA, Kolvek G, Zaikova N, Böhm M, Ariceta G, Jager KJ, Schaefer F, van Stralen KJ, Groothoff JW. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry. Nephrol Dial Transplant 2016;31:609-19.
  28. Breckenridge K, Bekker HL, Gibbons E, van der Veer SN, Abbott D, Briançon S, Cullen R, Garneata L, Jager KJ, Lønning K, Metcalfe W, Morton RL, Murtagh FE, Prutz K, Robertson S, Rychlik I, Schon S, Sharp L, Speyer E, Tentori F, Caskey FJ. How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrol Dial Transplant 2015;30:1605-1614
  29. Stel VS, Heinze G, Tripepi G, Zoccali C, Jager KJ. Seven essential tools of a cardiologist’s survival kit. Int J Cardiol 2015;191:87-89.
  30. Zoccali C, Bolignano D, D’Arrigo G, Dekker FW, Fliser D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Parati G, Rossignol P, Tripepi G, Vanholder R, Wiecek A, London G. Validity of vascular calcification as a screening tool and as a surrogate end-point in clinical research. Hypertension 2015;66:3-9. 
  31. Hruskova Z, Stel VS, Jayne D,  Aasarød K, de Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ. Characteristics and outcome of granulomatosis with polyangiitis (Wegener’s) and microscopic polyangiitis requiring renal replacement therapy in Europe – Results from the ERA-EDTA Registry. Am J Kidney Dis 2015;66:613-620.
  32. Jager KJ, Wanner C. Fifty years of ERA-EDTA Registry – a registry in transition.  Kidney Int Suppl 2015;5:12-14.
  33. Kainz A, Hronsky M, Stel VS, Jager KJ, Geroldinger A, Dunkler D, Heinze G, Tripepi G, Oberbauer R. Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025. Nephrol Dial Transplant 2015; suppl 4:iv113-iv118.
  34. Brück K, Jager KJ, Dounousi E, Kainz A, Nitsch D, Ärnlöv J, Rothenbacher D, Browne G, Capuano V, Ferraro PM, Ferrieres J, Gambaro G, Guessous I, Hallan S, Kastarinen M, Navis G, Otero Gonzalez A, Palmieri L, Romundstad S, Spoto B, Stengel B, Tomson C, Tripepi G, Völzke H, Wiecek A, Gansevoort R, Schöttker B, Wanner C, Vinhas J, Zoccali C, Van Biesen W, Stel VS on behalf of the European CKD Burden Consortium. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 2015; suppl 4:iv6-iv16.
  35. Wim van Biesen, van de Luijtgaarden MWM, Brown EA, Michel JP, van Munster BC, Jager KJ, van der Veer SN.  Nephrologists' perceptions regarding dialysis withdrawal and palliative care in Europe: lessons from a European Renal Best Practice survey.  Nephrol Dial Transplant 2015;30:1951-1958.
  36. Van de Luijtgaarden MWM, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remón C, Metcalfe W, Alfonso Miguel A, Kramar R, Aasarød K, Abu-Hanna A, Raymond T. Krediet RT, Schon S, Ravani P, Caskey FJ, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M.            Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant 2016;31:120-128.
  37. Lofaro D, Jager KJ, Abu-Hanna A, Groothoff JW, Arikoski P, Hoecker B, Roussey-Kesler G, Spasojević B, Verrina E, Schaefer F, van Stralen KJ. Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry. Nephrol Dial Transplant 2016;31:317-324.
  38. Wanner C, Jager KJ. Kidneys do not like excess body fat. Lancet Diabetes Endocrinol 2015;3:669-71.
  39. Brück K, Stel VS, Fraser S, De Goeij MCM, Caskey F, Abu-Hanna A, Jager KJ. Translational research in nephrology: chronic kidney disease prevention and public health. Clin Kidney J 2015;8:647-655.
  40. Krischock LA, van Stralen KJ, Verrina E, Tizard EJ, Bonthuis M, Reusz G, Hussain FK, Jankauskiene A, Novljan G, Spasojević-Dimitrijeva B, Podracka L, Zaller V, Jager KJ, Schaefer F.
    Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry. Pediatr Nephrol 2016;31:325-333.
  41. Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2016;31:831-841.
  42. Ioannou K, Stel VS, Dounousi E, Jager KJ, Papagianni A, Pappas K, Siamopoulos KC, Zoccali C, Tsakiris D. Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study. PLoS One. 2015 Sep 23;10(9):e0138461.
  43. Rossignol P, Massy Z, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M,  Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D.
    The double challenge of resistant hypertension and chronic kidney disease: A narrative review on diagnosis, epidemiology, pathophysiology and therapeutic options. The Lancet 2015;386:1588-1589.
  44. van den Beukel T, Hommel K, Kamper AL, Heaf J, Siegert C, Honig A, Jager KJ, Dekker FW, Norredam M. Differences in survival on chronic dialysis treatment between ethnic groups in Denmark: a population-wide, national cohort study. Nephrol Dial Transplant 2016;31:1160-1167.
  45. Nistor I, Bolignano D,Haller M, Nagler E, van der Veer SN, Jager KJ, Webster AC, Van Biesen W.
    Why creating Standardized Core Outcomes Set for Chronic Kidney Disease will improve clinical practice. Nephrol Dial Transplant 2017;8:1268-73.
  46. Lofaro D, Vogelzang JL, van Stralen KJ, Jager KJ, Groothoff JW. Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age. Pediatr Nephrol 2016;31:317-324.
  47. Ploos van Amstel S, Vogelzang JL, Starink MV, Jager KJ, Groothoff JW. Long-Term Risk of Cancer in Survivors of Pediatric ESRD. Clin J Am Soc Nephrol 2015;102198-2204.
  48. Hellemans R, Stel VS, Jager KJ, Bosmans JL, Abramowicz D.  Do elderly recipients really benefit from kidney transplantation? Transplant Rev 2015;29:197-201.
  49. Tjaden LA, Noordzij M, van Stralen KJ, Kuehni CE, Raes A, Cornelissen EAM, O'Brien C, Papachristou F, Schaefer F, Groothoff JW, Jager KJ. Racial Disparities in Access to and Outcomes of Kidney Transplantation in Children in Europe: Results From the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European Renal Association-European Transplant Association) Registry. Am J Kidney Dis 2016;67:293-301.
  50. Harambat J, Bonthuis M, Groothoff JW, Schaefer F, Tizard EJ, Verrina E, van Stralen KJ, Jager KJ. Lessons learned from the ESPN/ERA-EDTA Registry, Pediatr Nephrol 2016;31:2055-64.
  51. Brück K,  Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M,  Guessous I, Vinhas J,  Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Otero Gonzalez A, Bello AK, Ferrieres J,  Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D,  Ferraro PM, Nitsch D, Wanner C,  Jager KJ.
    Chronic kidney disease prevalence varies across European general population.
    J Am Soc Nephrol 2016;27:2135-2147.
  52. Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ.    Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry. Transplantation 2016;100;1955-1962.
  53. Tjaden LA, Maurice-Stam H, Grootenhuis MA, Jager KJ, Groothoff JW. Impact of Renal Replacement Therapy in Childhood on Long-Term Socioprofessional Outcomes: A 30-year Follow-Up Study. J Pediatr 2016;171:189-95.
  54. Hogan J, Couchoud C, Bonthuis M, Groothoff JW, Jager KJ, Schaefer F, Van Stralen KJ.
    Gender Disparities in Access to Pediatric Renal Transplantation in Europe: Data From the ESPN/ERA-EDTA Registry. Am J Transplant 2016;16:2097-105.
  55. van der Veer SN, van Biesen W, Bernaert P, Bolignano D, Brown EA, Covic A, Farrington K, Jager KJ, Kooman J, Macías-Núñez JF, Mooney A, van Munster BC, Topinkova E, Van Den Noortgate NJ, Wirnsberger G, Michel JP, Nistor I. Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults. Int Urol Nephrol 2016;48:859-869.
  56. Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C. Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns. Hypertension 2016;67:1093-1101.
  57. Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C. Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles. Hypertension 2016;67:1102-1110.
  58. Chesnaye NC, Schaefer F, Groothoff JW, Bonthuis M, Reusz G, Heaf JG, Lewis M, Maurer E, Paripović D, Zagozdzon I, van Stralen KJ, Jager KJ.            Mortality risk in European children with end-stage renal disease on dialysis. Kidney Int 2016;89:1355-62.
  59. Rao A, Brück K, Methven S, Evans R, Stel VS, Jager KJ, Hooft L, Ben-Shlomo Y, Caskey F.
    Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic Review. PLoS One 2016;11:e0155078. doi: 10.1371/journal.pone.0155078.
  60. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet 2016;388:294-306.
  61. Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamaño E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnés J, Garcia Bazaga Mde L, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, G Heaf J, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera Celestino C, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Stendahl M, Strakosha A, Süleymanlar G, Torres Guinea M, Varberg Reisæter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J 2016;9:457-69.
  62. Poinen K, Oliver MJ, Ravani P, Van der Veer SN, Jager KJ, Van Biesen W, Polkinghorne KR, Rosenfeld A, Lewin AM, Dulai M, Quinn RR. Willingness to participate in a randomized trial comparing catheters to fistulas for vascular access in incident hemodialysis patients: an international survey of nephrologists. Can J Kidney Health Dis 2016;3:33. doi: 10.1186/s40697-016-0125-6.
  63. Mekahli D, van Stralen KJ, Bonthuis M, Jager KJ, Balat A, Benetti E, Godefroid N, Edvardsson VO, Heaf JG, Jankauskiene A, Kerecuk L, Marinova S, Puteo F, Seeman T, Zurowska A, Pirenne J, Schaefer F, Groothoff JW.  Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) Registry. Am J Kidney Dis 2016; 68:782-788.
  64. Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet 2016;388(10041):294-306.
  65. Koopman JJ, Kramer A, van Heemst D, Åsberg A, Beuscart JB, Buturović-Ponikvar J, Collart F, Couchoud CG, Finne P, Heaf JG, Massy ZA, De Meester JM, Palsson R, Steenkamp R, Traynor JP, Jager KJ, Putter H. Measuring senescence rates of patients with end-stage renal disease while accounting for population heterogeneity: an analysis of data from the ERA-EDTA Registry. Ann Epidemiol 2016;26(11):773-779.
  66. Hölttä T, Bonthuis M, Van Stralen KJ, Bjerre A, Topaloglu R, Ozaltin F, Holmberg C, Harambat J, Jager KJ, Schaefer F, Groothoff JW. Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry. Pediatr Nephrol 2016;31:2317-2325.
  67. Farrington K, Covic A, Aucella F, Clyne N, de Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nitsch D, Stryckers M, Taal M, Tattersall J, Van Asselt D, Van den Noortgate N, Nistor I, Van Biesen W; ERBP guideline development group..
    Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2). Nephrol Dial Transplant 2016;31(suppl 2):ii1-ii66.
  68. Vidal E, van Stralen KJ, Chesnaye NC, Bonthuis M, Holmberg C, Zurowska A, Trivelli A, Da Silva JEE, Herthelius M, Adams B, Bjerre A, Jankauskiene A, Miteva P, Emirova K, Bayazit AK, Mache CJ, Sánchez-Moreno A, Harambat J, Groothoff JW,Jager KJ, Schaefer F, Verrina E; ESPN/ERA-EDTA Registry. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.Am J Kidney Dis 2017;69:617-625.
  69. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naicker S, Pecoits-Filho R, Yu XQ, Lameire N. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol 2017;13:90-103.
  70. van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM,Jager KJ. Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry. Nephrol Dial Transplant 2017;32:348-355.
  71. Liabeuf S, Van Stralen KJ, Caskey F, Tentori F, Pisoni RL, Sajjad A, Jager KJ, Massy ZA.
    Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country's healthcare expenditure and nephrologist workforce? Nephrol Dial Transplant 2017;10:1737-49.
  72. Tripepi G, D'Arrigo G, Jager KJ, Stel VS, Dekker FW, Zoccali C. Do we still need cross-sectional studies in Nephrology? Yes we do! Nephrol Dial Transplant 2017;32(suppl_2):ii19-ii22.
  73. Tjaden LA, Jager KJ, Bonthuis M, Kuehni CE, Lilien MR, Seeman T, Stefanidis CJ, Tse Y, Harambat J, Groothoff JW, Noordzij M. Racial variation in cardiovascular disease risk factors among European children on renal replacement therapy-results from the European Society of Paediatric Nephrology/European Renal Association - European Dialysis and Transplant Association Registry. Nephrol Dial Transplant 2017; 32:1908-1917.
  74. Jager KJ, Fraser SDS. The ascending rank of chronic kidney disease in the global burden of disease study. Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii121-ii128. doi: 10.1093/ndt/gfw330.
  75. Stel VS, Brück K, Fraser S, Zoccali C, Massy ZA,Jager KJ. International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue. Nephrol Dial Transplant 2017;32(suppl_2):ii129-ii135. doi: 10.1093/ndt/gfw420.
  76. Chesnaye NC, Schaefer F, Bonthuis M, Holman R, Baiko S, Baskın E, Bjerre A, Cloarec S, Cornelissen EA, Espinosa L, Heaf J, Stone R, Shtiza D, Zagozdzon I, Harambat J, Jager KJ, Groothoff JW, van Stralen KJ; ESPN/ERA-EDTA Registry Committee. Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis. Lancet 2017;389:2128-37.
  77. van Diepen M, Ramspek CL, Jager KJ, Zoccali C, Dekker FW. Prediction versus aetiology: common pitfalls and how to avoid them. Nephrol Dial Transplant 2017;32(suppl_2):ii1-ii5.
  78. Noordzij M, van Diepen M, Caskey FC, Jager KJ. Relative risk versus absolute risk: one cannot be interpreted without the other. Nephrol Dial Transplant 2017;32(suppl_2):ii13-ii18.
  79. Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA). The systemic nature of CKD. Nat Rev Nephrol 2017;13:344-58.
  80. Chesnaye NC, van Stralen KJ, Bonthuis M, Groothoff JW, Harambat J, Schaefer F, Canpolat N,Garnier A, Heaf J, de Jong H, Schwartz Sørensen S, Tönshoff B, Jager KJ. The association of donor and recipient age with graft survival in paediatric renal transplant  recipients in a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplantation Association Registry study. Nephrol Dial Transplant 2017; 32:1949-1956.
  81. Groothoff JW, Offringa M, Grootenhuis M, Jager KJ. Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study. Nephrol Dial Transplant,  Epub ahead of print, 17 July 2017.
  82. Yalcinkaya F, Bonthuis M, Erdogan BD, van Stralen KJ, Baiko S, Chehade H, Maxwell H, Montini G, Rönnholm K, Sørensen SS, Ulinski T, Verrina E, Weber S, Harambat J, Schaefer F, Jager KJ,
    Groothoff JW. Outcomes of renal replacement therapy in boys with prune belly syndrome: findings from the    ESPN/ERA-EDTA Registry.  Pediatr Nephrol, Epub ahead of print, 4 August 2017.
  83. Pippias M, Kramer A, Noordzij M, Afentakis N, Alonso de la Torre R, Ambühl PM, Aparicio Madre MI, Arribas Monzón F, Åsberg A, Bonthuis M, Bouzas Caamaño E, Bubic I, Caskey FJ, Castro de la Nuez P, Cernevskis H, de Los Ángeles Garcia Bazaga M, des Grottes JM, Fernández González R, Ferrer-Alamar M, Finne P, Garneata L, Golan E, Heaf JG, Hemmelder MH, Idrizi A, Ioannou K, Jarraya F, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic VV, Lopot F, Macario F, Magaz Á, Martín de Francisco AL, Martín Escobar E, Martínez Castelao A, Metcalfe W, Moreno Alia I, Nordio M, Ots-Rosenberg M, Palsson R, Ratkovic M, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Fernanda Slon Roblero M, Spustova V, Stas KJF, Stendahl ME, Stojceva-Taneva O, Vazelov E, Ziginskiene E, Massy Z, Jager KJ, Stel VS. The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014: a summary. Clin Kidney J 2017;10:154-169.
  84. Chesnaye NC, van Stralen KJ, Bonthuis M, Harambat J, Groothoff JW, Jager KJ. Survival in children requiring chronic renal replacement therapy. Pediatr Nephrol,  Epub ahead of print 15 May 2017.
  85. Jager KJ, Stel VS, Branger P, Guijt M, Busic M, Dragovic M, Diekmann F, Manyalich M, Di Ciaccio P, Nanni Costa A, Collett D, Mumford L, Haase B, Hemke A, Deme O, Mihály S, Murphy M, Couchoud C, Massy Z, Lingemann M, Rahmel A. The effect of differing kidney disease treatment modalities and organ donation and transplantation practices on health expenditure and patient outcomes.Nephrol Dial Transplant, Epub ahead of print 2 July 2017.
  86. Critselis E, Vlahou A, Stel VS, Morton RL. Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion. Nephrol Dial Transplant, Epub ahead of print 3 July 2017.
  87. Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ. Chronic kidney disease. Nature Reviews Nephrol Primer, Epub ahead of print 23 November 2017.